Carbidopa and Levodopa

Product NDC
0615-8536
11-digit product format
006158536
Labeler code
0615
Product ID
0615-8536_4bccc4b9-7399-4dd4-9146-c5b2714f299f
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Carbidopa and Levodopa
Dosage form
TABLET
Route
ORAL
Labeler
NCS HealthCare of KY, LLC dba Vangard Labs
Application
ANDA073589
Marketing category
ANDA
Marketing start
2024-05-01
Substance
CARBIDOPA; LEVODOPA
Active strength
25; 100 mg/1; mg/1
Pharmacologic classes
Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
MNX7R8C5VOCARBIDOPA38821-49-7CARBIDOPA
46627O600JLEVODOPA59-92-7LEVODOPA

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
0615-8536-050061585360515 TABLET in 1 BLISTER PACK (0615-8536-05) 15 tablet2024-09-10NoNoHistorical
0615-8536-280061585362828 TABLET in 1 BLISTER PACK (0615-8536-28) 28 tablet2024-09-10NoNoHistorical
0615-8536-390061585363930 TABLET in 1 BLISTER PACK (0615-8536-39) 30 tablet2024-09-10NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
CARBIDOPA AND LEVODOPA TABLETS, USPNCS HealthCare of KY, LLC dba Vangard Labs2024-12-06HUMAN PRESCRIPTION DRUG LABEL5